SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-20-211865
Filing Date
2020-08-06
Accepted
2020-08-06 16:00:54
Documents
53
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d59294d10q.htm   iXBRL 10-Q 1460201
2 EX-31.1 d59294dex311.htm EX-31.1 6193
3 EX-31.2 d59294dex312.htm EX-31.2 6156
4 EX-32.1 d59294dex321.htm EX-32.1 4958
  Complete submission text file 0001193125-20-211865.txt   4994060

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA ziop-20200730.xsd EX-101.SCH 41232
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ziop-20200730_cal.xml EX-101.CAL 24847
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ziop-20200730_def.xml EX-101.DEF 225165
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ziop-20200730_lab.xml EX-101.LAB 337322
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ziop-20200730_pre.xml EX-101.PRE 281535
10 EXTRACTED XBRL INSTANCE DOCUMENT d59294d10q_htm.xml XML 602035
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33038 | Film No.: 201081430
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences